Aura Health Provides Further Clarity Regarding Offering and Strategic Investor
23 2월 2019 - 1:01AM
NOT FOR DISTRIBUTION TO UNITED
STATES NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION,
DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR
IN PART, IN OR INTO THE UNITED STATES.
Aura Health Inc. (the “
Company” or
“
Aura”) (
CSE:BUZZ) is pleased to
provide further clarity on the press release dated February 21,
2019 with regards to the upsized private placement subscription
receipt offering (the “
Offering”), including the
participation by a strategic investor and the divestiture by Aura
of certain non-material U.S. assets.
Aura is currently in the process of divesting
its 30% interest in four medical marijuana clinics in the U.S. (the
“U.S. Assets”). The proceeds from the sale of the
U.S. Assets are not expected to be material to the Company.
The divestiture of the U.S. Assets will
constitute an additional escrow release condition to be satisfied
in order for the escrowed funds to be released to the Company
pursuant to the Offering.
The Company respects the clarification provided
by Aleafia Health Inc.’s February 21, 2019 press release and their
notification not to proceed with their previous investment
discussions in the Company at this time.
Pursuant to the terms of the private placement
to issue and sell up to $7.26 million of subscription receipts at
$0.22, the first close is expected to occur on or about February
27, 2019.
About Aura Health Inc.
Aura Health is building an international network
of vertically integrated cannabis assets. Through an established
product line of cannabis-infused edible products and oil extracts,
Aura is dedicated to building a high margin downstream business in
the medical marijuana sector. The Company holds convertible debt
that converts to 54% equity of HolyCanna, a cultivation and nursery
license holder in Israel.
For further information, please contact:
Daniel Cohen, CEO Aura Health Inc. (647)
202-1824
David Posner, ChairmanAura Health Inc. (647)
985-6727
Caution Regarding Forward-Looking
Information:
THE CANADIAN SECURITIES EXCHANGE HAS NOT
REVIEWED NOR DOES IT ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR
ACCURACY OF THIS RELEASE.
This news release may contain forward-looking
statements and information based on current expectations. These
statements should not be read as guarantees of future performance
or results. Such statements involve known and unknown risks,
uncertainties and other factors that may cause actual results,
performance or achievements to be materially different from those
implied by such statements. Such statements include the
participation of Aleafia in the Offering, the divestiture of the
U.S. Assets and the completion of the Offering, among others. There
is no certainty that any of these events will occur. Although such
statements are based on management's reasonable assumptions, there
can be no assurance that such assumptions will prove to be correct.
We assume no responsibility to update or revise them to reflect new
events or circumstances.
The Company's securities have not been
registered under the U.S. Securities Act of 1933, as amended (the
"U.S. Securities Act"), or applicable state securities laws, and
may not be offered or sold to, or for the account or benefit of,
persons in the United States or "U.S. Persons", as such term is
defined in Regulation S under the U.S. Securities Act, absent
registration or an applicable exemption from such registration
requirements. This press release shall not constitute an offer to
sell or the solicitation of an offer to buy nor shall there be any
sale of the securities in the United States or any jurisdiction in
which such offer, solicitation or sale would be unlawful.
Additionally, there are known and unknown risk
factors which could cause the Company's actual results, performance
or achievements to be materially different from any future results,
performance or achievements expressed or implied by the
forward-looking information contained herein. All forward-looking
information herein is qualified in its entirety by this cautionary
statement, and the Company disclaims any obligation to revise or
update any such forward-looking information or to publicly announce
the result of any revisions to any of the forward-looking
information contained herein to reflect future results, events or
developments, except as required by law.
Pharmadrug (CSE:BUZZ)
과거 데이터 주식 차트
부터 11월(11) 2024 으로 12월(12) 2024
Pharmadrug (CSE:BUZZ)
과거 데이터 주식 차트
부터 12월(12) 2023 으로 12월(12) 2024